UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) July 14, 2008
-------------------------------
AVOCENT CORPORATION
------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 000-30575 91-2032368
------------------------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
4991 CORPORATE DRIVE HUNTSVILLE, AL 35805
------------------------------------------------------------------------------
(Address of principal executive
offices) (Zip Code)
Registrant's telephone number, including area code (256) 430-4000
---------------------------
n/a
------------------------------------------------------------------------------
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On July 14, 2008, the Board of Directors of Avocent Corporation (the
"Company") approved the adoption of the Avocent Corporation 2008 Inducement
Equity Incentive Plan (the "Plan") and the form agreements thereto to provide
for the grant of stock options, stock appreciation rights, restricted stock,
restricted stock units, performance shares, performance units, deferred stock
units and dividend equivalents to new hires. The Company has reserved 350,000
shares of the Company's common stock to be available for awards pursuant to the
Plan.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit Number Description of Exhibit
-------------- ----------------------
99.14 2008 Inducement Equity Incentive Plan and forms thereto
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
AVOCENT CORPORATION
Date: July 15, 2008
By: /s/ Samuel F. Saracino
--------------------------------------------
Samuel F. Saracino
Executive Vice President of Legal and
Corporate Affairs, General Counsel, and Secretary
EXHIBIT INDEX
-------------
Exhibit Description of Exhibit
------- ----------------------
99.14 2008 Inducement Equity Incentive Plan and forms thereto